| Assay ID | Title | Year | Journal | Article |
|---|
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID102099 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MCF-7 breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID102536 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MALME-3M melanoma cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID105248 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-N breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID92124 | In vitro inhibition of cell growth | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101965 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-MB-231/ATCC breast cancer cell growth to 50% of level at the start experiment.. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID102102 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MCF-7 breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID210126 | In vitro tumor cell growth inhibition was reported as the concentration that reduces T-47D breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID105253 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-N breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID202308 | In vitro tumor cell growth inhibition was reported as the concentration that reduces SK-MEL-5 melanoma cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID85220 | In vitro tumor cell growth inhibition was reported as the concentration that reduces HS 578T breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101532 | In vitro tumor cell growth inhibition was reported as the concentration that reduces M14 melanoma cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID105044 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-MB-435 breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101964 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-MB-231/ATCC breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID91965 | Concentration which reduces cell growth to level at the start of the experiment was reported as the mean graph medium for all the cell lines tested in vitro conditions | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID102537 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MALME-3M melanoma cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101530 | In vitro tumor cell growth inhibition was reported as the concentration that reduces M14 melanoma cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID85221 | In vitro tumor cell growth inhibition was reported as the concentration that reduces HS 578T breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101001 | In vitro tumor cell growth inhibition was reported as the concentration that reduces LOXIMVI melanoma cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID202314 | In vitro tumor cell growth inhibition was reported as the concentration that reduces SK-MEL-5 melanoma cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID42303 | In vitro tumor cell growth inhibition was reported as the concentration that reduces BT-549 breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID210127 | In vitro tumor cell growth inhibition was reported as the concentration that reduces T-47D breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID201818 | In vitro tumor cell growth inhibition was reported as the concentration that reduces SK-MEL-2 melanoma cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID42304 | In vitro tumor cell growth inhibition was reported as the concentration that reduces BT-549 breast cancer cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID105043 | In vitro tumor cell growth inhibition was reported as the concentration that reduces MDA-MB-435 breast cancer cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID101002 | In vitro tumor cell growth inhibition was reported as the concentration that reduces LOXIMVI melanoma cell growth to 50% of level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| AID201816 | In vitro tumor cell growth inhibition was reported as the concentration that reduces SK-MEL-2 melanoma cell growth to level at the start experiment. | 1994 | Journal of medicinal chemistry, Mar-04, Volume: 37, Issue:5
| Synthesis of 2-methyl-(Z)-4-(phenylimino)naphth[2,3-d]oxazol-9-one , a monoimine quinone with selective cytotoxicity toward cancer cells. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |